Cardiovascular Medicine: Diagnostics, Drugs and Devices

Publication Date	January 2007
Publisher	BCC Research
Product Type	Report
Pages	214
ISBN Number	not applicable
Product Code	BCC00182

Buy this product or for assistance call +44 20 7060 7474

PDF £2,915.00$4849 | €3263

PRINT £2,915.00$4849 | €3263

FAX Order above formats by FAX

Summary

This market research report is an update of BCC's original report on the topic, published in 2001. BCC's goal in conducting this study is to provide an overview of the current and potential aspects of the global market for cardiovascular drugs, devices, and diagnostics in the pharmaceutical and biotechnology industries. The report determines the market size, market leaders, and factors affecting the market of cardiovascular drugs, devices, and diagnostics.

The overview of types of cardiovascular diseases and their prevalence is examined along with sales figures over the 5-year period from 2007 to 2012. Companies selling drugs, devices, and diagnostics are profiled; the factors affecting markets for these products, and how those markets are likely to change, are analyzed. Revenues have been broken down by the type of drug products, devices implanted, and diagnoses performed.

Our key objective is to present a comprehensive analysis of the current market and the future direction of cardiovascular drugs, devices, and diagnostics, with an emphasis on newer products.

Scope of study

This report contains:

Descriptions of various types of cardiovascular diagnostics such as in vitro tests and in vivo imaging techniques, devices such as drug eluting stents, and drugs such as Pfizer's blockbuster Lipitor
The current market status of cardiovascular diagnostics, devices and drugs, along with trends and forecasts for growth over the next 5 years
Technological issues including the latest developments and a thorough patent analysis
Analysis of the cardiovascular diagnostics, devices and drugs industry, both from a market and application perspective
Information about the major players in each market, including Medtronic and Boston Scientific in devices, Sanofi-Aventis and BMS in drugs, and Abbott in devices.

Report Highlights

The global market for cardiovascular diagnostics and therapy increased from $111 billion in 2006 to an estimated $119.8 billion in 2007. It should reach $192.4 billion through 2012, a compound annual growth rate (CAGR) of 9.9%.
The cardiovascular diagnostics market represents one of the largest sectors in the diagnostics industry chiefly due to the high prevalence rate of and mortality from cardiovascular disease.
Of the cardiovascular diagnostics, devices and drugs markets, the drugs market is the largest, worth an estimated $82.4 billion in 2007 and expected to reach $121.6 billion in 2012.

Content

Chapter 1 - Summary
- The Cardiovascular Diagnostic, Drug, And Device Markets
- Summary Table: Worldwide Revenue Of Cardiovascular Diagnostics, Drugs, And Devices, Through 2012 ($ Billions)
- Summary Figure: Worldwide Revenue Of Cardiovascular Diagnostics, Drugs, And Devices, 2005-2012 ($ Billions)
Chapter 2 - Overview
- What Is Cardiovascular (Cv) Disease?
- Causes Of Cardiovascular Disease
- Cardiovascular Diagnostics
- Cardiovascular Medicine
- Cardiovascular Devices
Chapter 3 - Cardiovascular Diseases
- Diseases Of The Heart (Cardio) And Diseases Of The Blood Vessels (Vascular)
  - Diseases Of The Heart
    - Coronary Artery Disease (Cad)
    - Coronary Heart Disease (Chd)
    - Cardiomyopathy
    - Valvular Heart Disease
    - Pericardial Disease
    - Congenital Heart Disease
    - Heart Failure
  - Disease Of Blood Vessels
    - Arteriosclerosis and Atherosclerosis
    - High Blood Pressure
    - Stroke
    - Aneurysm
    - Peripheral Arterial Disease and Claudication (Pad)
    - Vasculitis
    - Venous Incompetence
    - Venous Thrombosis
    - Varicose Veins
    - Lymphedema
  - Epidemiology Of Cardiovascular Disease
    - Global Distribution Pattern in 2004
    - Age
    - Gender
    - Role of Risk Factors
    - Risk Factors
    - Psychological and Social Factors
    - Prevention of Cardiovascular Disease
Chapter 4 - Prevalance Of Cardiovascular Diseases
- Major Cause Of Death
  - The Epidemiological Transition
  - Prevalence Of Heart Disease In Various Categories
    - Age
    - Gender
    - Race/ Ethnicity
    - Education
  - Prevalence Of Cardiovascular Diseases In The U.S.
  - Cost Of Cardiovascular Diseases In The U.S.
  - Prevalence And Cost Of Cardiovascular Diseases In Europe
  - Mortality Due To Cardiovascular Diseases
    - U.S.
    - Europe
Chapter 5 - Regulatory Issues
- Cardiovascular Drugs Approved By Fda
- Cardiovascular Devices Approved By The Fda
- Cardiovascular Drugs Recalled By Fda
- Cardiovascular Devices Recalled By Fda
- New Drug Applications
Chapter 6 - Cardiovascular Diagnostics
- Diagnostics Definition
- In Vitro Diagnostic
  - Biomarkers
    - Aspartate Aminotransferase (Ast/Got)
    - Lactate Dehydrogenase and its Isoenzyme Ld
    - Creatine Kinase (Ck) and its Isoenzyme Mb
    - Myoglobin
    - Cardiac Troponins
      - Reasons behind the Replacement of Ckmb with Troponins
    - Myoglobin/Carbonic Anhydrase Iii Ratio
    - Glycogen Phosphorylase Isoenzyme Bb
    - Heart Type Fatty Acid Binding Protein
  - Comparison Between Ctnt And Ctnl
    - Natriuretic Peptides as Cardiac Biomarkers
- Point-Of-Care Testing
  - Need For The Poct
    - Past, Present, and Future of Point-of-Care Testing
      - Past
      - Present
      - Future
  - Determining Whether To Use Poc Cardiac Testing In The Ed
    - Considerations of Turnaround Times
    - The Importance of Quantitative Results
    - Concerns about Standardization
  - Venues For Poc Testing
- In Vivo Diagnostics
  - Echocardiography
    - Need of the Echocardiography
  - Ultrasound
    - Advantages of Ultrasound
  - Mri
    - Need of Mri Scan
  - Positron Emission Tomography
  - Computed Tomography
    - Electron-Beam Computed Tomography (Ebct or Ultrafast Ct)
Chapter 7 - Cardiovascular Therapy
- Cardiovascular Drugs
  - Anti-Anginal Agents
  - Anti-Arrhythmic Agents
  - Anti-Hypertensive Drugs
  - Anti-Thrombotic Agents
  - Blood Lipid Lowering Agents
  - Drugs Used To Treat Congestive Heart Failure
- Cardiovascular Devices
  - Pacemakers
    - Defibrillators
    - Manual External Defibrillators
      - Manual Internal Defibrillator
      - Automated External Defibrillator
      - Semi-automated External Defibrillator
      - Implantable Cardioverter Defibrillator
    - Drug-Eluting Stents (Des)
    - Catheters
    - Valves
      - Mechanical Heart Valve
      - Biological Heart Valve
    - Ventricular Assist Device
    - Guidewires
    - Artificial Heart
  - Cardiac Resynchronization Therapy
    - Cardiac Resynchronization Therapy
    - Cardiac Resynchronization Therapy Devices
    - Difference between Biventricular Pacemaker and Standard Pacemaker
    - Use of Crt
    - Benefits of Crt
    - Potential Risks with Biventricular Pacemakers
Chapter 8 - Industry Structure
- Cardiovascular Diagnostics
  - Cardiac Biomarkers
    - Market Shares for Companies Providing Biomarker Tests
    - Effect of Poct on the Growth of Cardiac Biomarker Testing in Laboratory
  - Point Of Testing For Cardiac Biomarkers
    - Market Shares for Companies Providing Biomarker Tests
    - Factors Influencing the Growth of Point-of-Care Testing
    - Challenges for the Manufacturers
  - In-Vivo Diagnostics
    - Market Shares for Companies Providing In-Vivo Diagnostics
    - Factors Affecting the Growth of Cardiac Imaging or In vivo Diagnostics
- Cardiovascular Drugs
  - Anti-Anginal Agents
    - Market Shares for Anti-anginal Agents
  - Anti-Arryhthmic Agents
    - Market Shares for Anti-arrhythmic Agents
  - Anti-Hypertensive Agents
    - Market Shares for Anti-hypertensive Agents
  - Anti-Thrombotic Agents
    - Market Shares for Anti-thrombotic Agents
  - Blood Lipid Lowering Agents
    - Market Shares for Blood Lipid Lowering Agents
  - Drugs Treating Congestive Heart Failure
    - Market Shares for Drugs Treating Congestive Heart Failure
  - Factors Affecting The Sales Of Cardiovascular Drugs
    - Price Control/ Price pressure
    - Expiration of Patents
  - Major Factors For Future Growth
    - Life Expectancy
    - Access of Senior Citizens to Prescription Drugs
    - Patent Protection
    - Drugs Portfolio Management
    - Significant Potential of Developing Countries
- Cardiovascular Devices
  - Pacemakers
    - Market Shares of Companies Manufacturing Pacemakers
  - Cardioverter Defibrillators
    - Market Shares of Companies Manufacturing Conventional Cardioverter Defibrillators
    - Market Shares of Companies Manufacturing Crt-Defibrillators
  - Drug Eluting Stents
    - Market Shares of Companies Manufacturing Drug Eluting Stents
  - Catheters
    - Market Shares of Companies Manufacturing Catheters
  - Heart Valves
    - Market Shares of Companies Manufacturing Heart Valves
  - Ventricular Assist Device
    - Market Shares of Companies Manufacturing Ventricular Assist Devices
  - Guide Wires
    - Market Shares of Companies Manufacturing Guidewires
  - Factors Affecting The Sales Of Cardiovascular Devices
    - Aging Baby-Boomers
    - Regulation
    - Competitive Landscape of Technology
    - Shortening of Patent Lives
    - Business Taxes
Chapter 9 - Market Analysis Of Cardiovascular Diagnostics
- Cardiac Biomarkers
  - Cardiac Marker Testing By Type
  - Point-Of-Care Testing
  - In Vivo Diagnostics
  - Total Market Shares Of Cardiovascular Diagnostics Worldwide
Chapter 10 - Market Analysis Of Cardiovascular Drugs
- Anti-Anginal Agents
  - Anti-Arrhythmic Agents
- Anti-Hypertensive Agents
  - Anti-Thrombotic Agents
  - Blood Lipid Lowering Agents
  - Drugs Used To Treat Congestive Heart Failure
  - Total Worldwide Market Shares Of Cardiovascular Drugs
Chapter 11 - Cardiovascular Devices Market Analysis
- Pacemakers
  - Implantable Cardioverter Defibrillators
  - Drug Eluting Stents (Des) And Grafts
  - Catheters
  - Heart Valves
  - Ventricular Assist Devices
  - Guidewires
  - Artificial Heart
  - Total Market Shares Of Cardiovascular Devices Worldwide
Chapter 12 - New Developments/ Technological Innovations
- Diagnostics
  - Siemens Medical Solutions
  - Neurosonix Ltd
  - University Hospital Mannheim And Ospedali Riuniti Di Bergamo
  - Sorin
  - Philips
  - Topspin Medical
  - Sonosite, Inc.
  - Datascope Corporation
  - Response Biomedical
  - Astrazeneca
  - Bms & Pfizer
  - Decode Genetics
  - Encysive Pharmaceuticals Inc.
  - Epix Pharmaceuticals, Inc.
  - Lexicon Pharmaceuticals
  - Merck & Company
  - Momenta Pharmaceuticals, Inc.
  - Nile Therapeutics, Inc.
  - Pharmacopeia
  - Sanofi-Aventis
  - Takeda Pharmaceutical
  - University Of North Carolina
- Devices
  - Abbott
  - Abiomed, Inc.
  - Ats Medical
  - Cardiatis
  - Cryocath Technologies, Inc.
  - Cryocor, Inc.
  - Edward Lifesciences
  - Medtronic, Inc.
  - Methodist Debakey Heart Center
  - St. Jude Medical, Inc.
- Stem Cells And Heart Disease
Chapter 13 - Patent Analysis
- Total Patents
  - Patents By Year
  - Patents By Country
- Diagnostics Patents
  - Patents By Year
  - Patents By Country
  - Patents By Company
  - Patents By Assignee
- Drug Patents
  - Patents By Country
  - Patents By Company
    - Patents by Assignee
- Device Patents
  - Patents By Year
  - Patents By Country
  - Patents By Company
  - Patents By Assignee
Chapter 14 - Company Profiles For Diagnostics
- Abbott Laboratories Inc.
- Axis-Shield Plc
- Bayer Ag
- Beckman Coulter Inc.
- BiomÉRieux Inc.
- Biosite Incorporated
- Biosound Esaote Inc.
- Cambridge Heart Inc.
- Cholestech
- Covidien
- Dade Behring Inc.
- Deltex Medical Group Plc
- Epix Pharmaceuticals, Inc.
- Ep Medsystems
- Fonar Corporation
- Ge Healthcare
- Hypertension Diagnostic Inc.
- Inverness Medical Innovations, Inc
- Mallinckrodt
- Medison America Inc.
- Mortara Instrument Inc.
- Olympus America Inc.
- Ortho-Clinical Diagnostics, Inc. (Johnson & Johnson Co.)
- Philips Medical System
- Premd Inc.
- Response Biomedical Corp.
- Roche Holding
- Siemens
- Sonosite
Chapter 15 - Company Profiles For Drugs
- Abbott Laboratories Inc.
- Astrazeneca Plc
- Bayer Healthcare Pharmaceuticals Inc.
- Biovail Corporation
- Boehringer Ingelheim
- Bristol-Myers Squibb Company
- Cv Therapeutics Inc.
- Hoffman-La Roche Inc.
- Krka Group
- Les Laboratories Servier
- Merck & Co. Inc.
- Merck Kgaa
- Novartis Ag
- Pfizer Inc.
- Sanofi Aventis
- Schering Plough
- Solvay S.A.
- Ucb
- Wyeth
- Zentiva N.V.
Chapter 16 - Company Profiles For Devices
- Ambu International As
- Angiodynamics Inc.
- Asahi Intecc Co., Ltd.
- Ats Medical Inc.
- Bacchus Vascular
- Bioheart Inc.
- Biosensor International Group
- Boston Scientific Corporation
- Cardima Inc.
- Conor Medsystems, Llc
- Cook Group
- Cordis Corporation (Johnson &Johnson Co.)
- Corevalve
- C.R. Bard Inc.
- Cryocath
- Cryocor
- Datascope Corp.
- Edward Lifesciences Corp.
- Goodman Co. Ltd.
- Hansen Medical
- Hospira
- Japan Lifeline
- Medtronic
- Merit Medical System Inc.
- Nmt Medical Inc.
- Possis Medical
- Sorin Group
- St.Jude Medical
- Terumo
- Thoratec
- Vascular Solutions Inc.
- World Heart Corp.
- Zoll Medical Inc.
Chapter 17 - Appendix
List of Tables
- Table 1 Prevalence Of Stroke, Myocardial Infarction, And Angina Pectoris By Various Categories, 2005
- Table 2 Prevalence Of Cardiovascular Diseases In U.S., 2005 (Million People)
- Table 3 Cost Of Cardiovascular Diseases In U.S. Through 2012 ($ Billions)
- Table 4 Mortality Due To Cardiovascular Diseases In The U.S., 2005 (%)
- Table 5 Mortality Due To Cardiovascular Diseases In Europe, 2005 (%)
- Table 6 Cardiovascular Drugs Approved By Fda, 2002-2007*
- Table 7 Cardiovascular Devices Approved By The Fda, 2002-2007*
- Table 8 Cardiovascular Drugs Recalled By The Fda, 2002-2007*
- Table 9 Cardiovascular Devices Recalled By The Fda, 2002-2007*
- Table 10 Nt-Probnp In Acute Situations
- Table 11 Nt-Probnp In Primary Care Setting
- Table 12 Advantages Of Point Of Care Testing
- Table 13 Disadvantages Of Point Of Care Testing
- Table 14 Venues For Poc Testing
- Table 15 Types Of Echocardiograms
- Table 16 Types Of Doppler Ultrasound
- Table 17 Commonly Used Anti-Anginal Agents
- Table 18 Commonly Used Anti-Arrhythmic Agents
- Table 19 Commonly Used Anti-Hypertensive Agents
- Table 20 Commonly Used Blood Lipid Lowering Agents
- Table 21 Commonly Used Drugs To Treat Congestive Heart Failure
- Table 22 Pacemakers
- Table 23 Present Cardiac Marker Testing
- Table 24 Market Share Of Companies Providing Biomarker Tests, 2006 (%)
- Table 25 Present Point-Of-Care Testing For Cardiac Biomarkers
- Table 26 Market Share Of Companies Providing Point-Of-Care Testing For Cardiac Biomarkers, 2006 (%)
- Table 27 Present Imaging Systems For In-Vivo Diagnosis
- Table 28 Market Share Of Companies Providing In-Vivo Diagnostics, 2006 (%)
- Table 29 Global Market Leaders Of Anti-Anginal Agents
- Table 30 Market Share Of Companies Manufacturing Anti-Anginal Agents, 2006 (%)
- Table 31 Global Market Leaders Of Anti-Arrhythmic Agents
- Table 32 Market Share Of Companies Manufacturing Anti-Arrhythmic Agents, 2006 (%)
- Table 33 Global Market Leaders Of Anti-Hypertensive Agents
- Table 34 Market Share Of Companies Manufacturing Anti-Hypertensive Agents, 2006 (%)
- Table 35 Global Market Leaders Of Anti-Thrombotic Agents
- Table 36 Market Share Of Companies Manufacturing Anti-Thrombotic Agents, 2006 (%)
- Table 37 Global Market Leaders Of Blood Lipid Lowering Agents
- Table 38 Market Share Of Companies Manufacturing Blood Lipid Lowering Agents, 2006 (%)
- Table 39 Global Market Leaders Of Drugs Treating Congestive Heart Failure
- Table 40 Market Share Of Companies Manufacturing Drugs Treating Congestive Heart Failure, 2006 (%)
- Table 41 Global Market Leaders Of Manufacturers Of Pacemakers
- Table 42 Market Share Of Companies Manufacturing Pacemakers, 2006 (%)
- Table 43 Global Market Leaders Of Manufacturers Of Conventional Cardioverter Defibrillators
- Table 44 Global Market Leaders Of Manufacturers Of Crt-Defibrillators
- Table 45 Market Share Of Companies Manufacturing Conventional Cardioverter Defibrillators, 2006 (%)
- Table 46 Market Share Of Companies Manufacturing Crt-Defibrillators, 2006 (%)
- Table 47 Global Market Leaders Of Manufacturers Of Drug Eluting Stents
- Table 48 Market Share Of Companies Manufacturing Drug Eluting Stents, 2006 (%)
- Table 49 Global Market Leaders Of Manufacturers Of Catheters
- Table 50 Market Share Of Companies Manufacturing Catheters, 2006 (%)
- Table 51 Global Market Leaders Of Manufacturers Of Heart Valves
- Table 52 Market Share Of Companies Manufacturing Heart Valves, 2006 (%)
- Table 53 Global Market Leaders Of Manufacturers Of Ventricular Assist Devices
- Table 54 Market Share Of Companies Manufacturing Ventricular Assist Devices, 2006 (%)
- Table 55 Global Market Leaders Of Manufacturers Of Guide Wires
- Table 56 Market Share Of Companies Manufacturing Guidewires, 2006 (%)
- Table 57 Global Sales Of Cardiac Biomarkers, Through 2012 ($ Millions)
- Table 58 Estimated Worldwide Market For Cardiac Marker Testing By Type, Through 2012 ($ Millions)
- Table 59 Global Sales Of Point-Of-Care Testing, Through 2012 ($ Millions)
- Table 60 Global Sales Of In-Vivo Diagnostics, Through 2012 ($ Millions)
- Table 61 Worldwide Market Share Of Cardiovascular Diagnostics, 2006 (%)
- Table 62 Global Sales Of Anti-Anginal Drugs, Through 2012 ($ Billions)
- Table 63 Global Sales Of Anti-Arrhythmic Drugs, Through 2012 ($ Billions)
- Table 64 Global Sales Of Anti-Hypertensive Drugs, Through 2012 ($ Billions)
- Table 65 Global Sales Of Anti-Thrombotic Drugs, Through 2012 ($ Billions)
- Table 66 Global Sales Of Blood Lipid Lowering Drugs, Through 2012 ($ Billions)
- Table 67 Global Sales Of Drugs Used To Treat Congestive Heart Failure, Through 2012 ($ Billions)
- Table 68 Market Share Of Cardiovascular Drugs, 2006 (%)
- Table 69 Global Sales Of Pacemakers, Through 2012 ($ Millions)
- Table 70 Global Sales Of Conventional Implantable Cardioverter Devices, Through 2012 ($ Millions)
- Table 71 Global Sales Of Crt-Defibrillators, Through 2012 ($ Millions)
- Table 72 Global Sales Of Drug Eluting Stents And Grafts, Through 2012 ($ Millions)
- Table 73 Global Sales Of Catheters, Through 2012 ($ Millions)
- Table 74 Global Sales Of Heart Valves, Through 2012 ($ Millions)
- Table 75 Global Sales Of Ventricular Assist Devices, Through 2012 ($ Millions)
- Table 76 Global Sales Of Guidewires, Through 2012 ($ Millions)
- Table 77 Market Share Of Cardiovascular Devices, 2006 (%)
- Table 78 Total Number Of Significant Patents, 2005-2007
- Table 79 Total Number Of Patents By Country, 2005-2007
- Table 80 Patents For Diagnostics By Year, 2005-2007
- Table 81 Patents By Country For Diagnostics, 2005-2007
- Table 82 Number Of Patents By Company For Diagnostics
- Table 83 Number Of Patents By Assignee For Diagnostics, 2005-2007
- Table 84 Patents By Country For Drugs, 2005-2007
- Table 85 Number Of Patents By Company For Drugs, 2005-2007
- Table 86 Number Of Patents By Assignee For Devices, 2005-2007
- Table 87 Patents For Devices By Year, 2005-2007
- Table 88 Patents By Country For Devices, 2005-2007
- Table 89 Number Of Patents By Company For Devices, 2005-2007
- Table 90 Number Of Patents By Assignee For Devices, 2005-2007
- Table 91 Acronyms
List of Figures
- Figure 1 Prevalence Of Stroke, Myocardial Infarction, And Angina Pectoris By Age Group, 2005 (%)
- Figure 2 Prevalence Of Stroke, Myocardial Infarction, And Angina Pectoris By Gender, 2005 (%)
- Figure 3 Prevalence Of Stroke, Myocardial Infarction, And Angina Pectoris By Race/Ethinicity, 2005 (%)
- Figure 4 Prevalence Of Stroke, Myocardial Infarction, And Angina Pectoris By Education 2005 (%)
- Figure 5 Prevalence Of Cardiovascular Diseases In The U.S., 2005 (Million People)
- Figure 6 Cost Of Cardiovascular Diseases In The U.S., 2005-2012 ($ Billions)
- Figure 7 Mortality Due To Cardiovascular Diseases In The U.S. 2005 (%)
- Figure 8 Mortality Due To Cardiovascular Diseases In The U.S., 2005 (%)
- Figure 9 Cardiovascular Drugs Approved By Fda, 2002-2007*
- Figure 10 Cardiovascular Devices Approved By The Fda 2002-2007*
- Figure 11 Cardiovascular Devices Recalled By Fda, 2002-2007*
- Figure 12 Market Share Of Companies Providing Biomarker Tests, 2006 (%)
- Figure 13 Market Share Of Companies Providing Point-Of Care Testing For Cardiac Biomarkers, 2006 (%)
- Figure 14 Market Share Of Companies Providing In-Vivo Diagnostics, 2006 (%)
- Figure 15 Market Share Of Companies Manufacturing Anti-Anginal Agents, 2006 (%)
- Figure 16 Market Share Of Companies Manufacturing Anti-Arrhythmic Agents, 2006 (%)
- Figure 17 Market Share Of Companies Manufacturing Anti-Hypertensive Agents, 2006 (%)
- Figure 18 Market Share Of Companies Manufacturing Anti-Thrombotic Agents, 2006 (%)
- Figure 19 Market Share Of Companies Manufacturing Blood Lipid Lowering Agents, 2006 (%)
- Figure 20 Market Share Of Companies Manufacturing Drugs Treating Congestive Heart Failure, 2006 (%)
- Figure 21 Market Share Of Companies Manufacturing Pacemakers, 2006 (%)
- Figure 22 Market Share Of Companies Manufacturing Conventional Cardioverter Defibrillators, 2006 (%)
- Figure 23 Market Share Of Companies Manufacturing Crt-Defibrillators, 2006 (%)
- Figure 24 Market Share Of Companies Manufacturing Drug Eluting Stents, 2006 (%)
- Figure 25 Market Share Of Companies Manufacturing Catheters, 2006 (%)
- Figure 26 Market Share Of Companies Manufacturing Heart Valves, 2006 (%)
- Figure 27 Market Share Of Companies Manufacturing Ventricular Assist Devices, 2006 (%)
- Figure 28 Market Share Of Companies Manufacturing Guidewires, 2006 (%)
- Figure 29 Global Sales Of Cardiac Biomarkers, 2005-2012 ($ Millions)
- Figure 30 Global Sales Of Cardiac Biomarkers, By Type, 2005-2012 ($ Millions)
- Figure 31 Global Sales Of Point-Of-Care Testing, 2005-2012 ($ Millions)
- Figure 32 Global Sales Of In Vivo Diagnostics. 2005-2012 ($ Millions)
- Figure 33 Worldwide Market Share Of Cardiovascular Diagnostics, 2006 (%)
- Figure 34 Global Sales Of Anti-Anginal Drugs, 2005-2012($ Billions)
- Figure 35 Global Sales Of Anti-Arrhythmic Drugs, 2005-2012 ($ Billions)
- Figure 36 Global Sales Of Anti-Hypertensive Drugs, 2005-2012 ($ Billions)
- Figure 37 Global Sales Of Anti-Thrombotic Drugs, 2005-2012 ($ Billions)
- Figure 38 Global Sales Of Blood Lipid Lowering Drugs, 2005-2012 ($ Billions)
- Figure 39 Global Sales Of Drugs Used To Treat Congestive Heart Failure, 2005-2012 ($ Billions)
- Figure 40 Market Share Of Cardiovascular Drugs, 2006 (%)
- Figure 41 Global Sales Of Pacemakers, 2005-2012 ($ Millions)
- Figure 42 Global Sales Of Implantable Cardioverter Devices, 2005-2012 ($ Millions)
- Figure 43 Global Sales Of Implantable Crt-Defibrillators, 2005-2012 ($ Millions)
- Figure 44 Global Sales Of Drug Eluting Stents And Grafts, 2005-2012 ($ Millions)
- Figure 45 Global Sales Of Catheters, 2005-2012 ($ Millions)
- Figure 46 Global Sales Of Heart Valves, Through 2012 ($ Millions)
- Figure 47 Global Sales Of Ventricular Assist Devices, 2005-2012 ($ Millions)
- Figure 48 Global Sales Of Guidewires, 2005-2012 ($ Millions)
- Figure 49 Market Share Of Cardiovascular Devices, 2006 (%)
- Figure 50 Number Of Patents, 2005-2007
- Figure 51 Number Of Patents, Share By Year, 2005-2007 (%)
- Figure 52 Total Number Of Patents By Country, 2005-2007
- Figure 53 Patents For Diagnostics By Year, 2005-2007
- Figure 54 Patents By Country For Diagnostics, 2005-2007
- Figure 55 Total Number Of Patents By Company For Diagnostics, 2005-2007
- Figure 56 Number Of Patents By Assignee For Diagnostics, 2005-2007
- Figure 57 Patents By Country For Drugs, 2005-2007
- Figure 58 Total Number Of Patents By Company For Drugs, 2005-2007
- Figure 59 Number Of Patents By Assignee For Drugs, 2005-2007
- Figure 60 Patents For Devices By Year, 2005-2007
- Figure 61 Patents By Country For Devices, 2005-2007
- Figure 62 Total Number Of Patents By Company For Devices, 2005-2007
- Figure 63 Number Of Patents By Assignee For Devices, 2005-2007